HWP
ARKG icon

Highline Wealth Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Highline Wealth Partners’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1
Closed -$14 – 603
2024
Q2 		$14 Sell
1
-100
-99% -$2.52K ﹤0.01% 565
2024
Q1 		$2.89K Hold
101
– – ﹤0.01% 309
2023
Q4 		$3.3K Hold
101
– – ﹤0.01% 271
2023
Q3 		$2.8K Hold
101
– – ﹤0.01% 260
2023
Q2 		$3.43K Hold
101
– – ﹤0.01% 197
2023
Q1 		$3.02K Hold
101
– – ﹤0.01% 208
2022
Q4 		$2.84K Hold
101
– – ﹤0.01% 200
2022
Q3 		$3.31K Buy
+101
New +$3.71K ﹤0.01% 183

Other funds holding ARKG

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Highline Wealth Partners's ARKG Position: Q3 2024 in Review

Highline Wealth Partners sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2024, closing a stake of 1 share — an estimated $14 sold.

Highline Wealth Partners first reported a position in ARKG in Q3 2022 and held it in 8 quarters. The position peaked at $3.43K in Q2 2023. 238 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.

  • Highline Wealth Partners reported no remaining ARK Genomic Revolution ETF position as of Q3 2024 after selling out during the quarter.
  • Highline Wealth Partners sold 1 ARK Genomic Revolution ETF share in Q3 2024, an estimated $14.
  • Highline Wealth Partners first reported a position in ARK Genomic Revolution ETF in Q3 2022 and held it in 8 quarters.
  • Highline Wealth Partners's ARK Genomic Revolution ETF position peaked at $3.43K in Q2 2023.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.

Based on Highline Wealth Partners's 13F filing for Q3 2024, filed 25 Oct 2024.